Herman Weiss
Chairman chez TODOS MEDICAL LTD.
Profil
Herman Weiss is the founder of Fibro Control Israel Ltd.
He is currently the Chairman at Todos Medical Ltd.
since 2020.
Previously, he worked as the Director-Global Medical at Teva Pharmaceutical Industries Ltd.
from 2010 to 2016.
He also held the position of VP-Medical Affairs & Clinical Development at Catalent JNP, Inc. Additionally, he worked as a Professor at Yeshiva University.
Dr. Weiss has an MBA from George Washington University, an undergraduate degree from Ramapo College of New Jersey, and a doctorate from The Ohio State University College of Medicine.
Postes actifs de Herman Weiss
Sociétés | Poste | Début |
---|---|---|
TODOS MEDICAL LTD. | Chairman | 22/06/2017 |
Anciens postes connus de Herman Weiss
Sociétés | Poste | Fin |
---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Chief Tech/Sci/R&D Officer | 01/03/2016 |
Yeshiva University | Corporate Officer/Principal | - |
Fibro Control Israel Ltd.
Fibro Control Israel Ltd. Medical DistributorsDistribution Services Fibro Control Israel Ltd. develops devices to treat uterine fibroids. Its invasive technology is based on a novel approach that will overcome disadvantages found in other current fibroid treatments. The company was founded in 2008 and is headquartered in Herzeliya, Israel. | Founder | - |
JUNIPER PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Formation de Herman Weiss
George Washington University | Masters Business Admin |
Ramapo College of New Jersey | Undergraduate Degree |
The Ohio State University College of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
TODOS MEDICAL LTD. | Health Technology |
Entreprise privées | 2 |
---|---|
Catalent JNP, Inc.
Catalent JNP, Inc. Pharmaceuticals: MajorHealth Technology Catalent JNP, Inc. engages in the research and development of drugs and therapeutics. It offers analytical characterization and pre-formulation testing; formulation development; and clinical manufacturing of capsules and tablets. The company was founded in December 1986 and is headquartered in Somerset, NJ. | Health Technology |
Fibro Control Israel Ltd.
Fibro Control Israel Ltd. Medical DistributorsDistribution Services Fibro Control Israel Ltd. develops devices to treat uterine fibroids. Its invasive technology is based on a novel approach that will overcome disadvantages found in other current fibroid treatments. The company was founded in 2008 and is headquartered in Herzeliya, Israel. | Distribution Services |